# Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema

> **NCT05355818** · PHASE3 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 98 (actual)

## Conditions studied

- Chronic Hand Eczema

## Interventions

- **DRUG:** Delgocitinib
- **DRUG:** Cream vehicle

## Key facts

- **NCT ID:** NCT05355818
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-14
- **Primary completion:** 2024-12-05
- **Final completion:** 2024-12-17
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05355818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05355818, "Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05355818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*